The Patent Finder

JW Pharmaceutical Corporation

Also on record
Records under this name other than the patents JW Pharmaceutical Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.

Showing 1 to 3 of 3 · Back to JW Pharmaceutical Corporation

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,623,348Interferon-α (IFN-α) fused proteins comprising IFN-α and a cytoplasmic transduction peptide (CTP)
Formerly held
Lapsed on the fee record
Ended Jan 7, 2026 · USPTO record
Lapsed on the fee recordEnded Jan 7, 2026USPTO record
US 9,393,201Oxaliplatin nanoparticles and method for preparing same
Lapsed on the fee record
Ended Jul 19, 2020 · USPTO record
Lapsed on the fee recordEnded Jul 19, 2020USPTO record
US 8,383,355COMBINATION OF sPLA2 TYPE IIA MASS AND OXPL/APOB CARDIOVASCULAR RISK FACTORS FOR THE DIAGNOSIS/PROGNOSIS OF a CARDIOVASCULAR DISEASE/EVENT
Formerly held
Lapsed on the fee record
Ended Feb 26, 2017 · High confidence
Lapsed on the fee recordEnded Feb 26, 2017High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited